Second Sight Medical Products Inc
Change company Symbol lookup
Select an option...
EYES Second Sight Medical Products Inc
MTDR Matador Resources Co
BAC Bank of America Corp
DRGV Dragon Capital Group Corp
DRCR Dear Cashmere Group Holding Co
DMCD Detwiler Fenton Group Inc
DLDG DLD Group Inc
CNJG Jufeel International Group
CNGI Concordia Group Inc
CNCN Chun Can Capital Group
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company intends to develop Orion Visual Cortical Prosthesis which provides useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease or forms of cancer and trauma. Its product, The Argus II Retinal Prosthesis System (The Argus II) provides electrical stimulation of the retina to induce visual perception in blind individuals and helps in treating outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.

Closing Price
$0.89
Day's Change
-0.035 (-3.78%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.91
Day's Low
0.88
Volume
(Light)
Volume:
203,933

10-day average volume:
350,191
203,933

Display:

Providers:

UpdateCancel
7 providers
August 28, 2019
Second Sight to Present at September Investor Conferences

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics today announced that Will McGuire, President and Chief Executive Officer, and John Blake...(BusinessWire)

August 21, 2019
Global Electroceuticals/Bioelectric Medicine Market Analysis, Trends, and Forecasts 2019-2015 - ResearchAndMarkets.com

The "Electroceuticals/Bioelectric Medicine - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. Electroceuticals/Bioelectric Medicine market worldwide is projected to grow by US$12.9 Billion, guided...(BusinessWire)

August 06, 2019
Second Sight Reports Second Quarter 2019 Financial Results

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals...(BusinessWire)

July 30, 2019
Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, will release its financial results for the...(BusinessWire)

June 25, 2019
Researchers Present Latest Positive Results of Second Sight's Orion Visual Cortical Prosthesis Feasibility Study

Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, announced...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.